A rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...

Amazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...

Gilead is making headlines with its planned acquisition of Tubulis GmbH, a Germany-based company, for a maximum of five billion dollars. Th...

Insurers have been ordered by the regulator to assess claims denied or deductions made in all such cases and take appropriate action to pay...

The research, which was carried out by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), Moderna and other i...

Roche said that the production process for this drug is “very complex” and the company will do everything to ensure an equitable distributi...

Germany will become the first European Union country to start using the same experimental antibodies treatment credited with helping Donald...

Tests in animals suggest that antibody drugs work best when given early in infection to lower the amount of virus, he said. Once someone is...

Independent monitors had paused enrolment in the study two weeks ago because of a possible safety issue. But on Monday, the National Instit...

The long-acting single injection will be tested on recently diagnosed high-risk cases for its ability to prevent hospitalisation, typically...

Of the total 302 patients treated with the Lilly drug, five or 1.7%, had to be hospitalized or required an emergency room visit. That compa...

Convalescent Plasma Therapy is an experimental procedure where plasma from the blood of a recovered COVID-19 patient is transfused to a cri...

More research is needed to see whether the findings are confirmed in a clinical setting and how precisely the antibody defeats the virus.

The doctor from Orai in Uttar Pradesh was administered the plasma donated by a woman doctor from Canada who was the first COVID-19 patient ...

The experimental vaccine for Ebola, VSV-ZEBOV, has common side effects like site pain and transient fever that appeared and resolved within...

They work by inhibiting the body's blood vessel formation close to the tumour, which is thereby cut off from oxygen and nutrient supply.

Scientists from the NIAID have developed two experimental DNA vaccines that code for Ebola virus proteins from the Zaire and Sudan strains.